Charles J Casamento Relmada Therapeutics, Inc. (RLMD) insider trading activity

Charles J Casamento is Director of RELMADA THERAPEUTICS, INC.. Currently has a direct ownership of 0 shares of RLMD, which is worth approximately $0. The most recent transaction as insider was on Oct 22, 2024, when has been sold 13,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

0% 12M change

Total Value Held $0

CHARLES J CASAMENTO Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 22 2024	SELL Bona fide gift	-	13,000 Reduced 100.0%	0 Common Stock
Sep 09 2024	BUY Open market or private purchase	$33,280 $2.56 p/Share	13,000 Added 50.0%	13,000 Common Stock
Apr 01 2022	SELL Open market or private sale	$574,200 $29.0 p/Share	19,800 Reduced 100.0%	0 Common Stock
Apr 01 2022	BUY Exercise of conversion of derivative security	$64,152 $3.24 p/Share	19,800 Added 50.0%	19,800 Common Stock
Sep 22 2021	SELL Open market or private sale	$191,400 $29.0 p/Share	6,600 Reduced 39.76%	10,000 Common Stock
Sep 22 2021	BUY Exercise of conversion of derivative security	$46,000 $4.6 p/Share	10,000 Added 37.59%	16,600 Common Stock
Aug 17 2021	BUY Exercise of conversion of derivative security	$46,000 $4.6 p/Share	10,000 Added 40.49%	14,700 Common Stock
Jul 15 2021	SELL Open market or private sale	$104,808 $31.76 p/Share	3,300 Reduced 41.25%	4,700 Common Stock
Jun 01 2021	SELL Open market or private sale	$100,920 $33.64 p/Share	3,000 Reduced 30.15%	6,950 Common Stock
May 03 2021	SELL Open market or private sale	$114,660 $38.22 p/Share	3,000 Reduced 23.17%	9,950 Common Stock
Apr 01 2021	SELL Open market or private sale	$106,470 $35.49 p/Share	3,000 Reduced 18.81%	12,950 Common Stock
Mar 01 2021	SELL Open market or private sale	$101,610 $33.87 p/Share	3,000 Reduced 15.83%	15,950 Common Stock
Feb 01 2021	SELL Open market or private sale	$100,800 $33.6 p/Share	3,000 Reduced 13.67%	18,950 Common Stock
Jan 04 2021	SELL Open market or private sale	$96,330 $32.11 p/Share	3,000 Reduced 12.02%	21,950 Common Stock
Dec 01 2020	SELL Open market or private sale	$107,220 $35.74 p/Share	3,000 Reduced 10.73%	24,950 Common Stock
Nov 24 2020	SELL Bona fide gift	-	21,223 Reduced 43.16%	27,950 Common Stock
Nov 02 2020	SELL Open market or private sale	$90,870 $30.29 p/Share	3,000 Reduced 5.75%	49,173 Common Stock
Oct 01 2020	SELL Open market or private sale	$113,970 $37.99 p/Share	3,000 Reduced 5.44%	52,173 Common Stock

Also insider at

GTBP

GT Biopharma, Inc. Healthcare

Director

ETON

Eton Pharmaceuticals, Inc. Healthcare

Director

FWBI

First Wave BioPharma, Inc. Healthcare

Director

PXMD

PaxMedica, Inc. Healthcare

Director

CJC